James F. Oliviero III
Overview
James F. Oliviero III received an average of $2M in total compensation, including $459K in salary, at Checkpoint Therapeutics from 2015 to 2023.
2023Checkpoint TherapeuticsPresident, Chief Executive Officer and Director
2022Checkpoint TherapeuticsPresident, Chief Executive Officer and Director
2021Checkpoint TherapeuticsPresident, Chief Executive Officer and Director
2020Checkpoint TherapeuticsPresident, Chief Executive Officer and Director
2019Checkpoint TherapeuticsPresident, Chief Executive Officer and Director
2018Checkpoint TherapeuticsChief Executive Officer and President
2017Checkpoint TherapeuticsChief Executive Officer and President
2016Checkpoint TherapeuticsChief Executive Officer and President
2015Checkpoint TherapeuticsChief Executive Officer and President
Source: SEC filings on April 2, 2024, May 1, 2023, April 29, 2022, April 30, 2021, April 24, 2020, April 30, 2019, April 30, 2018, and April 28, 2017.
Related executives
We found two more executives who work or worked at Checkpoint Therapeutics.
News
Checkpoint Therapeutics CEO James Oliviero's 2023 pay slips 20% to $1.6M
April 2, 2024
Checkpoint Therapeutics CEO James Oliviero's 2022 pay slips 11% to $2M
May 1, 2023
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019